DONNA ROBERTSON: Open Payments
NPI 1144579921 · MARTINSVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$886 in 48 payments from 15 companies in 2025. Trend: 2023 $17 · 2024 $237 · 2025 $886
Food & beverage: $886
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $220 |
| ABBVIE INC. | 12 | $186 |
| AstraZeneca Pharmaceuticals LP | 4 | $62 |
| Janssen Pharmaceuticals, Inc | 4 | $62 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $60 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $59 |
| Lilly USA, LLC | 3 | $46 |
| Dexcom, Inc. | 2 | $40 |
| Exact Sciences Corporation | 1 | $33 |
| Amgen Inc. | 2 | $29 |
Products named: Ozempic, VRAYLAR, SPRAVATO, CAPLYTA, XIFAXAN, QULIPTA, FARXIGA, Wegovy.
Industry payments across VA — which companies pay providers there.
